Table 3.
Persons born in countries with an HBsAg prevalence ≥ 2% | Asia |
Africa | |
Mid-Pacific/South Pacific Islands | |
Eastern Europe including Russia and certain Mediterranean Countries | |
Amazon Basin of South America | |
Parts of the Caribbean | |
Indigenous populations of the Arctic, New Zealand and Australia | |
Other groups with HBsAg prevalence > 2% | Household and sexual contacts of HBsAg-positive persons |
Men who have sex with men | |
HIV-infected persons | |
Injecting drug users | |
All persons with elevated liver function tests |
HBsAg = hepatitis B surface antigen
Other persons with high risk for hepatitis B virus infection but with an HBsAg prevalence < 2% should be screened for HBV seromarkers and vaccinated if negative as per current Centers for Disease Control recommendations[2]